Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Under Documentation of Anemia in Older Adults in Primary Care Practices

Min Woo Hwang, Hirra A Chaudhary, William B Ershler

Blood (2024) 144 (Supplement 1): 7568.

https://doi.org/10.1182/blood-2024-208894

Published: 2024

Journal Articles

Real-World Experience of Individuals with Sickle Cell Disease Treated with Voxelotor: Initial Report from the Multicenter, Prospective Prospect Study

Biree Andemariam, Henny H. Billett, William B Ershler, Shayla Bergmann, Vishwas S. Sakhalkar, Alicia Chang, Payal Desai, Nirmish Shah, Sharon Pennington, Robin E. Miller, Laura M. Decastro, Michelle Xu, Brooke Hayward, Ching-Ray Yu, Darla K. Liles

Blood (2023) 142 (Supplement 1): 2499.

https://doi.org/10.1182/blood-2023-188746

Published: 2023

Journal Articles

Preliminary Results from a Multicenter Phase 2/3 Study of Next-Generation HbS Polymerization Inhibitor GBT021601 for the Treatment of Patients with Sickle Cell Disease

Santosh L. Saraf, Shehu Umar Abdullahi, Adeseye Michael Akinsete, Foluke A Fasola, Modupe Idowu, Sharon Pennington, William B Ershler, Marshall Patrick Stagg, Wai Chin, Eric Zimmerman, Adeyemi Adenola, Mira Patel Pochron, Eleanor A Lisbon

Blood (2023) 142 (Supplement 1): 274.

https://doi.org/10.1182/blood-2023-177781

Published: 2023

Journal Articles

How Sensitive Is the Sickle Prep? Clinical Implications

Sebastian R Mendez Marti, William B Ershler, Alan Sheinei, Chad Zik

Blood (2023) 142 (Supplement 1): 5335.

https://doi.org/10.1182/blood-2023-190718

Published: 2023

Journal Articles

Ineffective Erythropoiesis with Aging in Adults with Sickle Cell Disease

Upama Giri, Alan Sheinei, Chad Zik, Rania Fusisi, William B Ershler

Blood (2023) 142 (Supplement 1): 2505.

https://doi.org/10.1182/blood-2023-188068

Published: 2023

Journal Articles

Partial Red Cell Exchange Is an Effective Tool for Adequately Reducing Hemoglobin S Levels in Patients with Sickle Cell Disease and Improving Patient Outcomes Including Reduction in Acute Care Utilization

Alan Sheinei, Chad Zik, Rania Fusisi, William B Ershler

Blood (2023) 142 (Supplement 1): 5288.

https://doi.org/10.1182/blood-2023-189044

Published: 2023

Journal Articles

Preliminary Pharmacodynamic Results from a Multicenter Phase 2/3 Study of Next-Generation HbS Polymerization Inhibitor GBT021601 for the Treatment of Patients with Sickle Cell Disease

Mira Patel Pochron, Adeseye Michael Akinsete, Shehu Umar Abdullahi, Foluke A Fasola, Modupe Idowu, Sharon Pennington, William B Ershler, Marshall Patrick Stagg, Earl Fields, Morgan Sterling, Satheesh Chonat, Yuvika Paliwal, Karena Kong, David R Archer, Adeyemi Adenola, Eleanor A Lisbon

Blood (2023) 142 (Supplement 1): 1155.

https://doi.org/10.1182/blood-2023-188929

Published: 2023

Journal Articles

Implementation of an Adult Sickle Cell Center Directly Correlates with Improved Patient Outcomes and Decreased Acute Care Utilization

Alan Sheinei, William B Ershler, Chad Zik, Rania Fusisi

Blood (2023) 142 (Supplement 1): 7235.

https://doi.org/10.1182/blood-2023-188979

Published: 2023

Journal Articles

Crizanlizumab Use in Recurrent Neurologic Symptoms Attributed to Sickle Cell Disease Induced Moyamoya Syndrome

Chad Zik, Sheinei Alan, William B. Ershler

Blood (2022) 140 (Supplement 1): 11157–11158.

https://doi.org/10.1182/blood-2022-170745

Published: 2022

Journal Articles

The Impact of Hemoglobin Level on Risk of End-Organ Damage among Patients with Sickle Cell Disease - A Large-Scale, Longitudinal Analysis

William B Ershler, MD, Laura M De Castro, MD MHSc, Zahra Pakbaz, MD, Aaron Moynahan, Derek Weycker, PhD, Nhat Pham, Thomas E Delea, MSIA, Irene Agodoa, MD, Ze Cong, PhD

Blood (2020) 136 (Supplement 1): 27–28.

https://doi.org/10.1182/blood-2020-140572

Published: 2020

Journal Articles

Outcomes in Obese Patients Undergoing Induction Therapy for Acute Leukemia

Lauren Marie Dombrowski, PharmD, Leila Mohassel, PharmD, BCPS, BCOP, William B Ershler, MD

Blood (2017) 130 (Supplement 1): 5059.

https://doi.org/10.1182/blood.V130.Suppl_1.5059.5059

Published: 2017

Journal Articles

Development of HemSol-P (TM) , a Novel Platelet Storage Solution Permitting Storage at 4 o C

David H. Ho, PhD, Steingrimur Stefanson, PhD, William B Ershler, MD

Blood (2013) 122 (21): 3661.

https://doi.org/10.1182/blood.V122.21.3661.3661

Published: 2013

Journal Articles

Correction of Anemia in the Frail Elderly (CAFÉ): Results of a Randomized, Double-Blind, Placebo-Controlled Study with Darbepoetin Alfa in Elderly Patients with Chronic Unexplained Anemia

Arturo Loaiza-Bonilla, MD, Andrew Artz, MD MS, Francis Salerno, MD, Sean X Leng, MD, PhD, Shing-Shing Yeh, MD, Rex Biedenbender, MD, Stefan Gravenstein, MD, Jose Loera, MD, Zeba Shaheen Geloo, MD, William B Ershler, MD

Blood (2012) 120 (21): 5153.

https://doi.org/10.1182/blood.V120.21.5153.5153

Published: 2012

Journal Articles

Improved Survival Rates Among Acute Myeloid Leukemia (AML) Patients 65 to 74 Years: Population-Based Estimates Over Three Decades,

Mya S Thein, MD, Ahmedin Jemal, Maria R. Baer, MD, William B Ershler, MD, Jerome W Yates, MD, MPH

Blood (2011) 118 (21): 3591.

https://doi.org/10.1182/blood.V118.21.3591.3591

Published: 2011

Journal Articles

Proinflammatory state, hepcidin, and anemia in older persons

Luigi Ferrucci, Richard D. Semba, Jack M. Guralnik, William B. Ershler, Stefania Bandinelli, Kushang V. Patel, Kai Sun, Richard C. Woodman, Nancy C. Andrews, Robert J. Cotter, Tomas Ganz, Elizabeta Nemeth, Dan L. Longo

Blood (2010) 115 (18): 3810–3816.

https://doi.org/10.1182/blood-2009-02-201087

Published: 2010

Journal Articles

Baseline Characteristics of 65 Subjects in the Correction of Anemia with Darbepoetin alfa (DA) in the Community-Dwelling Frail Elderly (CAFÉ) Study.

Andrew S. Artz, MD, Sean X. Leng, MD, Shing-shing Yeh, PhD, MD, Patrick J. McKenna, Samisha N. Thomas, Paul Audhya, MD, Steve Doucette, PhD, Irene Q. Flores, RN, OCN, CRA, Z. Shana Geloo, MD, William B. Ershler, MD

Blood (2007) 110 (11): 3779.

https://doi.org/10.1182/blood.V110.11.3779.3779

Published: 2007

Journal Articles

Venous thrombosis in the elderly: more questions than answers

Roy L. Silverstein, Kenneth A. Bauer, Mary Cushman, Charles T. Esmon, William B. Ershler, Russell P. Tracy

Blood (2007) 110 (9): 3097–3101.

https://doi.org/10.1182/blood-2007-06-096545

Published: 2007

Journal Articles

Inflammation gone awry: aging or disease

William B. Ershler

Blood (2005) 105 (6): 2247.

https://doi.org/10.1182/blood-2004-12-4971

Published: 2005

Journal Articles

Serum Erythropoietin and Aging: A Longitudinal Analysis.

William B. Ershler, MD, Sheng Shan, PhD, Julie McKelvey, RN, Andrew S. Artz, MD, Neelima Denduluri, MD, Josephine Tecson, MD, Dennis D. Taub, PhD, Larry Brant, PhD, Luigi Ferrucci, MD, PhD, Dan L. Longo, MD

Blood (2004) 104 (11): 1628.

https://doi.org/10.1182/blood.V104.11.1628.1628

Published: 2004

Journal Articles

Circulating Erythropoietin (EPO) and Pro-Inflammatory Markers in Elderly (>/=65) Persons with and without Anemia.

Luigi Ferrucci, MD, PhD, Jack M. Guralnik, MD, PhD, Richard C. Woodman, MD, Stefania Bandinelli, MD, Fulvio Lauretani, MD, Annamaria Corsi, PhD, Paulo H.M. Chaves, MD, PhD, William B. Ershler, MD, Dan L. Longo, MD

Blood (2004) 104 (11): 1629.

https://doi.org/10.1182/blood.V104.11.1629.1629

Published: 2004

NARROW

Under Documentation of Anemia in Older Adults in Primary Care Practices

Real-World Experience of Individuals with Sickle Cell Disease Treated with Voxelotor: Initial Report from the Multicenter, Prospective Prospect Study

Preliminary Results from a Multicenter Phase 2/3 Study of Next-Generation HbS Polymerization Inhibitor GBT021601 for the Treatment of Patients with Sickle Cell Disease

How Sensitive Is the Sickle Prep? Clinical Implications

Ineffective Erythropoiesis with Aging in Adults with Sickle Cell Disease

Partial Red Cell Exchange Is an Effective Tool for Adequately Reducing Hemoglobin S Levels in Patients with Sickle Cell Disease and Improving Patient Outcomes Including Reduction in Acute Care Utilization

Preliminary Pharmacodynamic Results from a Multicenter Phase 2/3 Study of Next-Generation HbS Polymerization Inhibitor GBT021601 for the Treatment of Patients with Sickle Cell Disease

Implementation of an Adult Sickle Cell Center Directly Correlates with Improved Patient Outcomes and Decreased Acute Care Utilization

Crizanlizumab Use in Recurrent Neurologic Symptoms Attributed to Sickle Cell Disease Induced Moyamoya Syndrome

The Impact of Hemoglobin Level on Risk of End-Organ Damage among Patients with Sickle Cell Disease - A Large-Scale, Longitudinal Analysis

Outcomes in Obese Patients Undergoing Induction Therapy for Acute Leukemia

Development of HemSol-P (TM) , a Novel Platelet Storage Solution Permitting Storage at 4 o C

Correction of Anemia in the Frail Elderly (CAFÉ): Results of a Randomized, Double-Blind, Placebo-Controlled Study with Darbepoetin Alfa in Elderly Patients with Chronic Unexplained Anemia

Improved Survival Rates Among Acute Myeloid Leukemia (AML) Patients 65 to 74 Years: Population-Based Estimates Over Three Decades,

Proinflammatory state, hepcidin, and anemia in older persons

Baseline Characteristics of 65 Subjects in the Correction of Anemia with Darbepoetin alfa (DA) in the Community-Dwelling Frail Elderly (CAFÉ) Study.

Venous thrombosis in the elderly: more questions than answers

Inflammation gone awry: aging or disease

Serum Erythropoietin and Aging: A Longitudinal Analysis.

Circulating Erythropoietin (EPO) and Pro-Inflammatory Markers in Elderly (>/=65) Persons with and without Anemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only